{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:30:09Z","timestamp":1790289009427,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1007\/s11912-004-0079-1","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T16:52:08Z","timestamp":1180716728000},"page":"476-482","source":"Crossref","is-referenced-by-count":11,"title":["Gestational trophoblastic neoplasia: The management of relapsing patients and other recent advances"],"prefix":"10.1007","volume":"6","author":[{"given":"Naveed","family":"Sarwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward S.","family":"Newlands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Seckl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"79_CR1","first-page":"7","volume-title":"Gestational Trophoblastic Diseases","author":"World Health Organization","year":"1983","unstructured":"World Health Organization: Gestational Trophoblastic Diseases, Technical Report series 692. Geneva, Switzerland: WHO; 1983:7\u201381."},{"key":"79_CR2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1471-0528.1982.tb04693.x","volume":"89","author":"PA Jacobs","year":"1982","unstructured":"Jacobs PA, Hunt PA, Matsuura JS, et al.: Complete and partial hydatidiform mole in Hawaii: cytogenetics, morphology and epidemiology. Br J Obstet Gynaecol 1982, 89:258\u2013266.","journal-title":"Br J Obstet Gynaecol"},{"key":"79_CR3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1521-6934(03)00049-X","volume":"17","author":"SJ Steigrad","year":"2003","unstructured":"Steigrad SJ: Epidemiology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol 2003, 17:837\u2013847.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"79_CR4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/gyno.2000.5839","volume":"78","author":"JA Tidy","year":"2000","unstructured":"Tidy JA, Gillespie AM, Bright N, et al.: Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy. Gynecol Oncol 2000, 78:309\u2013312.","journal-title":"Gynecol Oncol"},{"key":"79_CR5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(00)02432-6","volume":"356","author":"MJ Seckl","year":"2000","unstructured":"Seckl MJ, Fisher RA, Salerno G, et al.: Choriocarcinoma and partial hydatidiform moles. Lancet 2000, 356:36\u201339.","journal-title":"Lancet"},{"key":"79_CR6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(04)16898-0","volume":"364","author":"MJ Seckl","year":"2004","unstructured":"Seckl MJ, Fillmore R, Foskett M, et al.: Routine terminations of pregnancy: Should we screen for gestational trophoblastic neoplasia. Lancet 2004, 364:705\u2013707.","journal-title":"Lancet"},{"key":"79_CR7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/clinchem\/47.2.308","volume":"47","author":"LA Cole","year":"2001","unstructured":"Cole LA, Shahabi S, Butler SA, et al.: Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases. Clin Chem 2001, 47:308\u2013315.","journal-title":"Clin Chem"},{"key":"79_CR8","first-page":"1142","volume":"8","author":"R Agarwal","year":"2002","unstructured":"Agarwal R, Strickland S, McNeish IA, et al.: Doppler ultrasonography of the uterine artery and the response to chemotherapy in patients with gestational trophoblastic tumors. Clin Cancer Res 2002, 8:1142\u20131147.","journal-title":"Clin Cancer Res"},{"key":"79_CR9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1148\/radiol.2223010035","volume":"222","author":"AK Lim","year":"2002","unstructured":"Lim AK, Agarwal R, Seckl MJ, et al.: Embolization of residual uterine vascular malformations in patients with gestational trophoblastic tumours. Radiology 2002, 222:640\u2013644.","journal-title":"Radiology"},{"key":"79_CR10","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/0140-6736(91)92603-Y","volume":"338","author":"MJ Seckl","year":"1991","unstructured":"Seckl MJ, Rustin GJ, Newlands ES, et al.: Pulmonary embolism, pulmonary hypertension, and choriocarcinoma. Lancet 1991, 338:1313\u20131315.","journal-title":"Lancet"},{"key":"79_CR11","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/1097-0142(197609)38:3<1373::AID-CNCR2820380342>3.0.CO;2-E","volume":"38","author":"KD Bagshawe","year":"1976","unstructured":"Bagshawe KD: Risk and prognostic factors in trophoblastic neoplasia. Cancer 1976, 38:1373\u20131385.","journal-title":"Cancer"},{"key":"79_CR12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1525-1438.2001.011001073.x","volume":"11","author":"EI Kohorn","year":"2001","unstructured":"Kohorn EI: The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment. Int J Gynecol Cancer 2001, 11:73\u201377.","journal-title":"Int J Gynecol Cancer"},{"key":"79_CR13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/oxfordjournals.annonc.a059037","volume":"6","author":"C Boshoff","year":"1995","unstructured":"Boshoff C, Begent RH, Oliver RT, et al.: Secondary tumours following etoposide containing therapy for germ cell cancer. Ann Oncol 1995, 6:35\u201340.","journal-title":"Ann Oncol"},{"key":"79_CR14","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1067\/mob.2000.108077","volume":"183","author":"LC Wong","year":"2000","unstructured":"Wong LC, Ngan HY, Cheng DK, Ng TY: Methotrexate infusion in low-risk gestational trophoblastic disease. Am J Obstet Gynecol 2000, 183:1579\u20131582.","journal-title":"Am J Obstet Gynecol"},{"key":"79_CR15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/gyno.2001.6271","volume":"82","author":"JS Kwon","year":"2001","unstructured":"Kwon JS, Elit L, Mazurka J, Moens F, Schmuck ML: Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia. Gynecol Oncol 2001, 82:367\u2013370.","journal-title":"Gynecol Oncol"},{"key":"79_CR16","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1200\/JCO.2002.07.166","volume":"20","author":"IA McNeish","year":"2002","unstructured":"McNeish IA, Strickland S, Holden L, et al.: Low risk persistent gestational trophoblastic disease: outcome following initial treatment with low-dose methotrexate and folinic acid, 1992\u20132000. J Clin Oncol 2002, 20:1838\u20131844. This paper describes the single-center experience of efficacy, relapse rates, and salvage therapies for patients initially treated with methotrexate and folinic acid for low-risk GTN.","journal-title":"J Clin Oncol"},{"key":"79_CR17","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1200\/JCO.1996.14.10.2769","volume":"14","author":"GJ Rustin","year":"1996","unstructured":"Rustin GJ, Newlands ES, Lutz JM, et al.: Combination but not single agent methotrexate chemotherapy for gestational trophoblastic tumours (GTT) increases the incidence of second tumours. J Clin Oncol 1996, 14:2769\u20132773.","journal-title":"J Clin Oncol"},{"key":"79_CR18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/gyno.2001.6533","volume":"85","author":"EI Kohorn","year":"2002","unstructured":"Kohorn EI: Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance? Gynecol Oncol 2002, 85:36\u201339.","journal-title":"Gynecol Oncol"},{"key":"79_CR19","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.1997.15.7.2636","volume":"15","author":"M Bower","year":"1997","unstructured":"Bower M, Newlands ES, Holden L, et al.: EMA\/CO for high-risk gestational trophoblastic tumours: results from a cohort of 272 patients. J Clin Oncol 1997, 15:2636\u20132643.","journal-title":"J Clin Oncol"},{"key":"79_CR20","first-page":"465","volume":"47","author":"ES Newlands","year":"2002","unstructured":"Newlands ES, Holden L, Seckl MJ, et al.: Management of brain metastases in patients with high-risk gestational trophoblastic tumors. J Reprod Med 2002, 47:465\u2013471. This paper summarizes the largest single-center experience for the management of GTN involving the CNS.","journal-title":"J Reprod Med"},{"key":"79_CR21","first-page":"817","volume":"80","author":"JC Schink","year":"1992","unstructured":"Schink JC, Singh DK, Rademaker AW, et al.: Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease. Obstet Gynecol 1992, 80:817\u2013820.","journal-title":"Obstet Gynecol"},{"key":"79_CR22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1479-828X.1994.tb01047.x","volume":"34","author":"M Quinn","year":"1994","unstructured":"Quinn M, Murray J, Friedlander M, et al.: EMACO in high risk gestational trophoblast disease: the Australian experience. Gestational Trophoblast Subcommittee, Clinical Oncological Society of Australia. Aust N Z J Obstet Gynaecol 1994, 34:90\u201392.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"Suppl 1","key":"79_CR23","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S0020-7292(98)80010-6","volume":"60","author":"SJ Kim","year":"1998","unstructured":"Kim SJ, Bae SN, Kim JH, et al.: Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT: 25 years experiences of KRI-TRD. Int J Gynaecol Obstet 1998, 60(Suppl 1):S85-S96.","journal-title":"Int J Gynaecol Obstet"},{"key":"79_CR24","first-page":"44","volume":"43","author":"JR Lurain","year":"1998","unstructured":"Lurain JR: Management of high-risk gestational trophoblastic disease. J Reprod Med 1998, 43:44\u201352.","journal-title":"J Reprod Med"},{"key":"79_CR25","first-page":"97","volume":"34","author":"Y Xiang","year":"1999","unstructured":"Xiang Y, Yang X, Han S: Methotrexate combined chemotherapy for chemorefractory gestational trophoblastic tumour [in Chinese]. Zhonghua Fu Chan Ke Za Zhi 1999, 34:97\u2013100.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"79_CR26","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1054\/bjoc.2000.1176","volume":"82","author":"LS Dobson","year":"2000","unstructured":"Dobson LS, Lorigan PC, Coleman RE, Hancock BW: Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease. Br J Cancer 2000, 82:1547\u20131552.","journal-title":"Br J Cancer"},{"key":"79_CR27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/gyno.2000.5813","volume":"78","author":"H Matsui","year":"2000","unstructured":"Matsui H, Suzuka K, Iitsuka Y, et al.: Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors. Gynecol Oncol 2000, 78:28\u201331.","journal-title":"Gynecol Oncol"},{"key":"79_CR28","first-page":"460","volume":"47","author":"AJ Papadopoulos","year":"2002","unstructured":"Papadopoulos AJ, Foskett M, Seckl MJ, et al.: Twenty-five years\u2019 clinical experience of placental site trophoblastic tumors. J Reprod Med 2002, 47:460\u2013464. The optimal management for PSTT will probably never be defined, but this paper provides substantial insight into how this rare tumor should be managed and which prognostic factors are likely to be of key importance.","journal-title":"J Reprod Med"},{"key":"79_CR29","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S1521-6934(03)00092-0","volume":"17","author":"ES Newlands","year":"2003","unstructured":"Newlands ES: The management of recurrent and drug-resistant gestational trophoblastic neoplasia (GTN). Best Pract Res Clin Obstet Gynaecol 2003, 17:905\u2013923.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"79_CR30","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1200\/JCO.2000.18.4.854","volume":"18","author":"ES Newlands","year":"2000","unstructured":"Newlands ES, Mulholland PJ, Holden L, et al.: Etoposide and cisplatin\/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA\/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol 2000, 18:854\u2013859. The choice of effective salvage regimens for patients relapsing from high-risk GTN is unclear. This paper describes the single-center use of cisplatin in the EP\/EMA schedule. The results indicate that this is likely to be the best regimen either alone or in combination with surgical removal of known sites of active disease. An international randomized phase II\/III trial is now required.","journal-title":"J Clin Oncol"},{"key":"79_CR31","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/1097-0142(19861001)58:7<1407::AID-CNCR2820580704>3.0.CO;2-2","volume":"58","author":"AN Gordon","year":"1986","unstructured":"Gordon AN, Kavanagh JJ, Gershenson DM, et al.: Cisplatin, vinblastine, and bleomycin combination therapy in resistant gestational trophoblastic disease. Cancer 1986, 58:1407\u20131410.","journal-title":"Cancer"},{"key":"79_CR32","first-page":"189","volume":"34","author":"B DuBeshter","year":"1989","unstructured":"DuBeshter B, Berkowitz RS, Goldstein DP, Bernstein M: Vinblastine, cisplatin and bleomycin as salvage therapy for refractory high-risk metastatic gestational trophoblastic disease. J Reprod Med 1989, 34:189\u2013192.","journal-title":"J Reprod Med"},{"key":"79_CR33","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/1097-0142(19891101)64:9<1829::AID-CNCR2820640912>3.0.CO;2-G","volume":"64","author":"M Azab","year":"1989","unstructured":"Azab M, Droz JP, Theodore C, et al.: Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high-risk gestational trophoblastic tumors. Cancer 1989, 64:1829\u20131832.","journal-title":"Cancer"},{"key":"79_CR34","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/gyno.1995.1074","volume":"56","author":"JT Soper","year":"1995","unstructured":"Soper JT, Evans AC, Rodriguez G, et al.: Etoposide-platin combination therapy for chemorefractory gestational trophoblastic disease. Gynecol Oncol 1995, 56:421\u2013424.","journal-title":"Gynecol Oncol"},{"key":"79_CR35","first-page":"438","volume":"49","author":"H Matsui","year":"2004","unstructured":"Matsui H, Iitsuka Y, Suzuka K, et al.: Salvage chemotherapy for high-risk gestational trophoblastic tumor. J Reprod Med 2004, 49:438\u2013442.","journal-title":"J Reprod Med"},{"key":"79_CR36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/gyno.1996.0110","volume":"61","author":"WB Jones","year":"1996","unstructured":"Jones WB, Schneider J, Shapiro F, Lewis JL Jr: Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases. Gynecol Oncol 1996, 61:126\u2013130.","journal-title":"Gynecol Oncol"},{"key":"79_CR37","first-page":"108","volume":"18","author":"R Gerson","year":"1997","unstructured":"Gerson R, Serrano A, Del Carmen Bello M, et al.: Response of choriocarcinoma to paclitaxel: case report and review of resistance. Eur J Gynaecol Oncol 1997, 18:108\u2013110.","journal-title":"Eur J Gynaecol Oncol"},{"key":"79_CR38","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/sj.bjc.6601664","volume":"90","author":"IA McNeish","year":"2004","unstructured":"McNeish IA, Kanfer EJ, Haynes R, et al.: Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours. Br J Cancer 2004, 90:1169\u20131175.","journal-title":"Br J Cancer"},{"key":"79_CR39","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1471-0528.2004.00065x.x","volume":"111","author":"Z Pandian","year":"2004","unstructured":"Pandian Z, Seckl MJ, Smith R, Lees DA: Gestational choriocarcinoma: an unusual presentation with response to gemcitabine and surgery. BJOG 2004, 111:382\u2013384.","journal-title":"BJOG"},{"key":"79_CR40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1006\/gyno.1995.1247","volume":"58","author":"PL Giacalone","year":"1995","unstructured":"Giacalone PL, Benos P, Donnadio D, Laffargue F: High-dose chemotherapy with autologous bone marrow transplantation for refractory metastatic gestational trophoblastic disease. Gynaecol Oncol 1995, 58:383\u2013385.","journal-title":"Gynaecol Oncol"},{"key":"79_CR41","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1006\/gyno.1997.4677","volume":"65","author":"K Besien van","year":"1997","unstructured":"van Besien K, Verschraegen C, Mehra R, et al.: Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin and etoposide (ICE) and stem cell rescue. Gynaecol Oncol 1997, 65:366\u2013369.","journal-title":"Gynaecol Oncol"},{"key":"79_CR42","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/gyno.2002.6583","volume":"85","author":"S Knox","year":"2002","unstructured":"Knox S, Brooks SE, Wong-You-Cheong J, et al.: Choriocarcinoma and epithelial trophoblastic tumor: successful treatment of relapse with hysterectomy and highdose chemotherapy with peripheral stem cell support: a case report. Gynecol Oncol 2002, 85:204\u2013208.","journal-title":"Gynecol Oncol"},{"key":"79_CR43","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/1097-0142(19831101)52:9<1728::AID-CNCR2820520929>3.0.CO;2-U","volume":"52","author":"A Athanassiou","year":"1983","unstructured":"Athanassiou A, Begent RH, Newlands ES, et al.: Central nervous system metastases of choriocarcinoma: 23 years\u2019 experience at Charing Cross Hospital. Cancer 1983, 52:1728\u20131735.","journal-title":"Cancer"},{"key":"79_CR44","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/S0140-6736(99)00541-3","volume":"353","author":"SK Lo","year":"1999","unstructured":"Lo SK, Montgomery JN, Blagden S, et al.: Reducing incidence of headache after lumbar puncture and intrathecal cytotoxics. Lancet 1999, 353:2038\u20132039.","journal-title":"Lancet"},{"key":"79_CR45","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1200\/JCO.1989.7.7.900","volume":"7","author":"GJ Rustin","year":"1989","unstructured":"Rustin GJ, Newlands ES, Begent RH, et al.: Weekly alternating chemotherapy (EMA\/CO) for treatment of central nervous systems of choriocarcinoma. J Clin Oncol 1989, 7:900\u2013903.","journal-title":"J Clin Oncol"},{"key":"79_CR46","first-page":"154","volume":"22","author":"A Altintas","year":"2001","unstructured":"Altintas A, Vardar MA: Central nervous system involvement in gestational trophoblastic neoplasia. Eur J Gynaecol Oncol 2001, 22:154\u2013156.","journal-title":"Eur J Gynaecol Oncol"},{"key":"79_CR47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1148\/radiology.200.1.8657926","volume":"200","author":"W Small Jr","year":"1996","unstructured":"Small W Jr, Lurain JR, Shetty RM, et al.: Gestational trophoblastic disease metastatic to the brain. Radiology 1996, 200:277\u2013280.","journal-title":"Radiology"},{"key":"79_CR48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/gyno.1997.4920","volume":"68","author":"NR Schechter","year":"1998","unstructured":"Schechter NR, Mychalczak B, Jones W, Spriggs D: Prognosis of patients treated with whole-brain radiation therapy for metastatic gestational trophoblastic disease. Gynecol Oncol 1998, 68:183\u2013192.","journal-title":"Gynecol Oncol"},{"key":"79_CR49","first-page":"337","volume":"47","author":"CM Feltmate","year":"2002","unstructured":"Feltmate CM, Genest DR, Goldstein DP, Berkowitz RS: Advances in the understanding of placental site trophoblastic tumor. J Reprod Med 2002, 47:337\u2013341.","journal-title":"J Reprod Med"},{"key":"79_CR50","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/gyno.2000.5777","volume":"77","author":"ZS Tuncer","year":"2000","unstructured":"Tuncer ZS, Vegh GL, Fulop V, Genest DR, et al.: Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor. Gynecol Oncol 2000, 77:389\u2013393.","journal-title":"Gynecol Oncol"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-004-0079-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-004-0079-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-004-0079-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T16:52:51Z","timestamp":1587574371000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-004-0079-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["79"],"URL":"https:\/\/doi.org\/10.1007\/s11912-004-0079-1","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}